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Abstract Blood flow presents several interesting phenomena
in microcirculation that can be used to develop microfluidic
devices capable to promote blood cells separation and analysis
in continuous flow. In the last decade there have been numer-
ous microfluidic studies focused on the deformation of red
blood cells (RBCs) flowing through geometries mimicking
microvessels. In contrast, studies focusing on the deformation
of white blood cells (WBCs) are scarce despite this phenom-
enon often happens in the microcirculation. In this work, we
present a novel integrative microfluidic device able to perform
continuous separation of a desired amount of blood cells,
without clogging or jamming, and at the same time, capable
to assess the deformation index (DI) of both WBCs and
RBCs. To determine the DI of both WBCs and RBCs, a hy-
perbolic converging microchannel was used, as well as a suit-
able image analysis technique to measure the DIs of these
blood cells along the regions of interest. The results show that
the WBCs have a much lower deformability than RBCs when
subjected to the same in vitro flow conditions, which is direct-
ly related to their cytoskeleton and nucleus contents. The pro-
posed strategy can be easily transformed into a simple and
inexpensive diagnostic microfluidic system to simultaneously
separate and assess blood cells deformability.
Keywords Microfluidic devices . Cell separation and
deformability . Hyperbolic microchannel . Blood on chips .
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1 Introduction
Blood is an extremely information-rich and easily accessible
tissue, which can be used to diagnose several diseases with
multiple techniques. However, due to the complex blend of
cells it requires the isolation of a limited number of cells, so an
accurate analysis can be realized and eventually applied to a
variety of biomedical applications, such as diagnostics, thera-
peutics and cell biology (Gossett et al. 2010). Most of the
standard techniques used for cell separation and sorting are
often labour intensive or require additional external labels to
identify cells (Jinlong et al. 2008; Pinho et al. 2013). For these
reasons, label-free microfluidic techniques have been raising
interest, since they avoid the use of biochemical labels that
may change the cell properties and increase costs (Gossett
et al. 2010). Therefore, intrinsic biomarkers, such as cell size,
electrical polarization, density, deformability and/or hydrody-
namic properties are being explored (Chen et al. 2008; Hou
et al. 2010; Kim et al. 2010; Pinho et al. 2013; Shevkoplyas
et al. 2005). Concerning cells separation based on their size,
microstructures such as micro-pillar arrays, micro-weir and
membranes with holes have been used as a simple, non-
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destructive and easy integrative step to be implemented, in
order to archive a single and complete device (Bradley et al.
2012; Chen et al. 2008; Yang et al. 1999). Nevertheless, sev-
eral separation microfluidic devices are based in dead-end
filtration, which might lead to clogging or jamming
(Agbangla et al. 2012; Chen et al. 2007; Georgieva et al.
2010). To overcome this issue, cross-flow filtration has being
used (Tae Goo et al. 2014), operating under similar size-
exclusion precepts, with the fluid flowing perpendicular to
the micro-pillar arrays or micro-weir filters. Thereby, the
rejected cells continue to travel in the direction of primary
flow, while selected cells flow into a separated outlet (Chen
et al. 2008; Gossett et al. 2010). Ji and his colleagues (Ji et al.
2008) have compared four main types of silicon-based
microfilters and they have found that the cross-flow filtration
approach is the most efficient way of sorting RBCs and
WBCs. Additionally this microfilter was the most suitable
for handling blood flow avoiding problems associated with
aggregations of cells and filter clogging. Recently, some re-
search works regarding the plasma separation from whole
blood (Chen et al. 2008; VanDelinder and Groisman 2006),
white blood cells (WBCs) from whole blood (VanDelinder
and Groisman 2007), fluorescent polystyrene beads separated
by sizes (Metz et al. 2004) and neonatal rat cardiac cell pop-
ulation from whole blood (Murthy et al. 2006) have been
reported. However, to the best of our knowledge, no study
has reported until now an integrative microfluidic device, ca-
pable of separating a small amount of blood cells (WBCs and
red blood cells (RBCs)) from the initial blood fluid, and at the
same time, studying and detecting changes in their
deformability, through the deformation index (DI) assessment
of isolated individual cells. In fact, in microfluidics and cell
biology fields there is a need of a better understanding of the
flow behaviour and deformation of WBCs in an in vitro envi-
ronment. This type of environment was already shown to be
very different from the in vivo ones, where WBCs adapt their
shape (possibly by deformation) penetrating through the walls
of vascular endothelial cells, by activation of pro-
inflammatory mediators (cytokines, chemokines, or bacterial
peptides) (Liu and Wang 2004). Since WBCs are a set of
several types of different and specialized cells, they are usu-
ally subdivided in: granulocytes (neutrophils, basophils, and
eosinophils), characterized by the presence of differently
staining granules in their cytoplasm or agranulocytes (lym-
phocytes, monocytes, and macrophages), characterized by
the apparent absence of granules in their cytoplasm
(Khismatullin 2009). Due to the polymorphism and complex-
ity of these cells, they should be studied individually, in order
to verify their specificities of deformability and hydrodynamic
properties, such as their sizes, cytoplasmatic contents and den-
sities. In the group of agranulocytes, peripheral blood mono-
nuclear cells (PBMC) (i.e., lymphocyte, monocyte or macro-
phage) are main actors in inflammatory processes and linked
to many diseases, such as rheumatoid arthritis (Tanino et al.
2009), atherosclerosis (Ortega et al. 2012), asthma (Covar
et al. 2010), HIV (Fu et al. 2011), cancer (Frampton et al.
2013), among others. Moreover, they are a potential source
of non-invasive biomarkers for diagnosis and monitoring of
many diseases (Maes et al. 2013). In this research, we develop
a pillar-type cross-flow filtration microfluidic device to sepa-
rate and collect RBCs and a specific type of WBCs, the
PBMC, and then perform the individual deformation assess-
ment of them, based on the extensional flow approach. The
latter methodology was adopted due to the ability of providing
a detailed quantitative description of the degree of deforma-
tion of blood cells under a controlled homogeneous extension-
al flow field, in a region of homogeneous extension rate.
Studies focusing on the extensional flow effect on the blood
cells deformability are scarce, despite this phenomenon often
happens in the microcirculation, particularly when there is a
sudden change in geometry and consequently, there is a dra-
matic change of the cells velocity and deformability. Recent
studies performed by Lee et al. (2009), Yaginuma et al. (2013)
and Faustino et al. (2014) have investigated RBCs behaviour
under the effect of a extensional flow in hyperbolic converg-
ing microchannels. However, in the literature there are few
studies concerning the effect of extensional-dominated flows
on the deformation degree of WBCs. Therefore, the main
purpose of this study is the development of an integrative
microfluidic device able to separate from an initial in vitro
blood sample, a low amount of blood cells (PBMCs and
RBCs), and at the same time, evaluate their deformability
through a hyperbolic converging microchannel.
2 Materials and methods
2.1 Microfluidic device design and fabrication
The microfluidic device used in the present work was de-
signed to include a cross-flow filtration barrier to separate a
low amount of WBCs (i.e., PBMCs) and RBCs from an
in vitro blood sample, as well as several sequences of hyper-
bolic channels, in the outlet of the sub-channels, to perform
deformability assessment on the separated blood cells. A sche-
matic view of the microfluidic device with dimensions of the
main channel, 55×500×17,482 μm (height × width × length),
is shown in Fig. 1. The pillar-type filtration barrier was set
with a total of 42 rectangular pillars with dimensions of 55×
50 μm (width × length), spaced by 10 μm, and the triplicate
sequences of the hyperbolics were set in the outlet of the four
sub-channels, with dimension of 55×20×383 μm (height ×
width × length). To perform the deformability assessment hy-
perbolic converging microchannels were designed with
382 μm of length, as well as widths of 400 and 20 μm at the
wide and narrow sizes, respectively, corresponding to
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hyperbolic contractions with a Hencky strain of~3. The poly-
dimethylsiloxane (PDMS) microchannels were fabricated
using soft lithographic technique from a mask-pattern fabri-
cated by photolitography technique using photoresistant SU-
8, as previously reported by Lima et al. (2008).
2.2 Working fluid protocol
The working fluid used in this study was Dextran 40 (Sigma-
Aldrich, USA) solution containing 2 % of haematocrit (Hct
2%, v/v) of RBCs and equal amount of PBMCs. PBMCs were
collected from whole human blood by adapting the procedure
described by Sigma-Aldrich® (Sigma-Aldrich 2011), with the
commercial solution of Histopaque-1077 (Sigma-Aldrich,
USA). Briefly, venous human blood samples from healthy
donors were collected into 10 mL BD-Vacutainers (BD,
USA) tubes containing ethylenediaminetetraacetic acid
(EDTA). The whole blood was divided in two equal parts in
order to obtain RBCs and PBMCs with the following proce-
dures: (i) RBCs collection, 3 mL of whole blood was centri-
fuged immediately after collection at 2500 rpm for 10 min at
4 °C. After removing the buffy coat and plasma, the packed
RBCs were re-suspended and washed twice in physiological
salt solution (PSS) with 0.9 % NaCl (B. Braun Medical,
Germany); (ii) PBMCs collection: 3 mL of whole blood was
carefully added to 3 mL of Histopaque-1077 (Sigma-Aldrich,
USA) at room temperature. After centrifuged for 30 min at
1900 rpm, the upper layer corresponding to plasma was
discarded. Therefore, the opaque interface containing
PBMCs was washed three times with 6 mL of Hank’s
Balanced Salt Solution without calcium or magnesium
(HBSS, Life Technologies, USA) during 10 min at
1500 rpm, in order to remove possible contamination of plate-
lets or RBCs. Then, the washed PBMCs were re-suspended in
1 mL of tissue culture medium, RPMI-1040 (Sigma-Aldrich,
USA), and kept at 4 °C until being used in the experiments.
Immediately before the experiments, the final working fluid
was prepared by mixing together the collected RBCs and
PBMCs in Dextran 40 solution (10 %, w/v). Dextran 40 is
frequently used as substitute of the blood plasma, since it
minimizes not only the sedimentation of the blood cells during
the experimental assays but also cell clogging phenomenon.
2.3 Experimental set-up
The high-speed video microscopy system used in the present
study consisted of an inverted microscope (IX71, Olympus)
combined with a high-speed camera (Fastcam SA3, Photron,
USA). The PDMS microchannel was placed and fixed in the
microscope and the flow rate of the working fluids was kept
constant at 100 μL/min by means of a syringe pump (PHD
Ultra, Harvard Apparatus, USA) with a 5 mL syringe
(Terumo, Japan). The fluids at the four outlets of the sub-
channels (O1, O2, O3 and O4) were collected into separated
Eppendorfs to be further evaluated, concerning the cell sepa-
ration efficiency, as shown in Fig. 2. At the same time, the
images of the flowing cells at the established flow rate were
captured by the high speed camera at a frame rate of 2000
frames/s and a shutter speed ratio of 1/75 000, which mini-
mized the dragging of the cells at the high flow rate in study.
All the experimental assays were performed at room temper-
ature (T=22±1 °C).
Fig. 1 Schematic view of the microfluidic device with zoom of the pillar-type filtration barrier to promote blood cells separation, as well as the
hyperbolic sequence section to assess the deformation index of those blood cells. I, Inlet; O1, Outlet 1; O2, Outlet 2; O3, Outlet 3; O4, Outlet 4
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2.4 Determination of the blood cells separation
Individual Eppendorfs were placed close to the four outlets of
the sub-channels, called as O1, O2, O3 and O4, allowing the
collection, and further evaluation of the amount of blood cells
that were separated by the cross-flow filtration barrier. Thus,
an equal volume of 250 μL from each sub-channel was treated
with RBCs lysis buffer (GBiosciences, USA) in a ratio of 1:2
(v/v), during 15 min at room temperature. This procedure en-
abled that only the RBCs were selectively lysed without af-
fecting the viability of WBCs, and therefore, the PBMCs
could be counted using a Neubauer chamber with accuracy.
The method to count the PBMCs in a Neubauer chamber used
in this work was the same as the recommended by Luttmann
et al. (2006), where blood cells are counted within the four big
squares of the Neubauer chamber. This procedure was per-
formed in triplicate for each outlet and in two separated assays
done in different days using the blood of two different healthy
donors (n=6).
2.5 Image analysis
The experimental images recorded in each test were trans-
ferred to a computer, processed and analysed by an image
handling software, ImageJ (1.46r, NIH, USA). Using this soft-
ware, DI of the blood cells were calculated similarly as previ-
ously reported by Pinho et al. (2013). For all the measure-
ments, major and minor axis lengths of the blood cells were
used to determine RBCs and PBMCs DIs. The formula used
to calculate the DI is presented as Eq. (1):
DI ¼ Lmajor − Lminorð Þ
Lmajor þ Lminorð Þ ð1Þ
where, Lmajor and Lminor refer to major and minor axis lengths
of the blood cell, respectively.
For the assessment of the DI of each blood cells, 92 indi-
vidual cells of RBCs and 76 PBMCswere randomlymeasured
in the centre line position along the hyperbolic channel.
Hence, a total of 168 individual blood cells were assessed to
calculate the DI.
3 Results and discussion
3.1 Separation of blood cells in the microfluidic device
Themain goal of this study is the development of a simple and
integrative microfluidic device capable to perform at once and
in continuous flow, the separation of a certain amount of blood
cells from an initial in vitro blood sample, and simultaneously
use the reduced amount of blood cells to perform their
deformability assessment. Hence, this device can be a useful
microfluidic tool, capable to assess and study the blood cells
DIs, as they can be used as label-free biomarkers for the as-
sessment of blood diseases. To gain insight in the
deformability behavior of leukocyte cells, we have decided
to investigate the PBMCs (i.e., lymphocyte, monocyte or mac-
rophage), which are main actors in the inflammatory process-
es and linked to many blood diseases.
To achieve the best flow conditions to perform the
microfluidic experimental assays, several experimental pa-
rameters had to be previously studied. One of the most critical
parameter in all microfluidic tests is the choice of the most
suitable flow rate that better fits on the purpose of the
microfluidic study. Therefore, in order to evaluate the optimal
flow rate for the better cell separation efficiency, a series of
trial assays were previously made in the range between 10 and
200 μl/min. In these screening experiments, the blood cells
(PBMCs and RBCs) were tracked at three representative po-
sitions (middle of the main channel, just above the pillars-wall
and at the region between the middle position and pillars-wall)
Fig. 2 Main experimental
set-up used to perform the
microfluidic tests
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at the cross-flow filtration region of the microchannel device
(data not shown). To assess this data the manual tracking
BMtrackJ^ plugin (Meijering et al. 2006) from the image han-
dling software, ImageJ (1.46r, NIH) was used to track PBMCs
and RBCs, as similarly reported by Leble et al. (2011) and
shown in Fig. 3 (more details in the supplementary video 1).
Figure 3 shows clearly that the pillars provide a barrier to
WBCs as a PBMC is rolling along the cross-flow pillars pro-
moting this cell to flow within the main channel. In contrast,
RBCs tend to deform and pass through the pillars into the
branch channel.
As a result, the flow rate 100 μl/min was considered to
be the most suitable to perform this study, due to the main-
tained flow stability, absence of clogging or jamming of the
cells, as well as a better separation of the tracked blood
cells along the cross-flow filtration channel. Therefore, this
optimized flow rate allowed that just a small concentration
of blood cells flow through the cross-flow pillar barrier,
which promoted the optimum conditions to assess the indi-
vidual cells DI. In contrast, the lower flow rates used in the
screening experiments (10, 25 and 50 μl/min), often led to
severe clogging and jamming of the blood cells. In partic-
ular, the PBMCs were often trapped within the pillars bar-
rier with these lower flow rates, restricting the continuity of
these assays and consequently compromising the assess-
ment of the cells DIs. A possible explanation for these
observed clogging and jamming phenomena is that at lower
flow rates, stagnation regions where the cells velocity are
close to zero, are more likely to happen around the cross-
flow pillars. On the other hand, tests with higher flow rate,
such as 200 μl/min, have resulted in high internal pressure
and leakage of the working fluid. Note that high flow rates
also increase the complexity of controlling the working
fluid within the microchannel and measuring the
deformability of the cells flowing through the hyperbolic
contractions. Thus, according to these screening results, it
was decided to select the flow rate of 100 μl/min, as the
most suitable to perform our experimental tests.
Table 1 shows the amount of PBMCs cells/mL counted by
means of a Neubauer chamber, as previously described in
section 2.4., after the RBCs lysis treatment be applied into
all the fluid samples collected at the four outlets.
The results shown in Table 1 demonstrate that even with a
very simple cross-flow filtration geometry (consisting in just
one linear sequence of square pillars), it is possible to obtain a
desired amount of PBMCs for the further assessment of cells
DI, which in this case represents about 25 % of cells from the
initial working fluid. Figure 4 shows a representative illustra-
tion of the separation strategy and blood cells flowing through
the pillar cross-flow barrier into the four outlets.
As it can be seen in Fig. 4, the combination of the cross-
flow filtration with an optimal flow rate generates a cell-free
layer in the lateral outlets promotes a decreasing on the total
amount of blood cells flowing through that outlets. These
decreasing of PBMCs in O1 and O4 were also qualitatively
observed in the amount of RBCs. However, the qualitative
data of the collected RBCs into these outlets had to be
sacrificed in order to improve the accuracy of the counted
PBMCs within the Neubauer chamber. As a result, the
RBCs were lysed as previously described in the section 2.4.,
with minimal cellular effect on the WBCs.
3.2 Blood cells deformation assessment
In literature there are several published works regarding the
correlation between RBCs, abnormal deformability and some
diseases (e.g., malaria (Suwanarusk et al. 2004), diabetes
(Sabo et al. 1993), coronary diseases (Yaylali et al. 2013),
among others), showing the interest of this topic by several
research groups. However, even though WBCs are known to
be important cells, as they defend our body against bacteria,
virus and other harmful agents, there are few works published
in literature concerning the in vitro assessment of their
deformability, motion and interaction with other blood cells
in microfluidic devices. Therefore, in this study we measured
the DI of both RBCs and WBCs (i.e., PBMCs) flowing
through hyperbolic microchannels located downstream the
cross-flow microfilters, designated as O1 and O4 (cf. Fig. 1).
As described above, the cross-flow filtration used in this study
has promoted the reduction of the concentration of both
Fig. 3 Trajectories of both RBC
and PBMC flowing around the
pillars. The PBMC rolls along the
pillars in the direction of primary
flow whereas the RBC deforms
and pass through the narrow gap
between the pillars into the branch
channel (see also supplementary
video 1)
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WBCs and RBCs passing to the outlets O1 and O4 (as shown
in Table 1 and Fig. 4). This low concentration was appropriate
to obtain video images with single individual blood cells.
However, this is not the case of the hyperbolic channels locat-
ed around the outlets O2 andO3, where the high concentration
of cells does not allow to accurately perform deformability
assessment of individual blood cells.
After the cells concentration be decreased from the initial
in vitro blood sample, due to the cross-flow filtration, the
initial flow rate was slightly reduced with the presence of
reservoirs located immediately before of each hyperbolic se-
quences in the four outlets of the microfluidic device (cf.
Fig. 1). These geometries allowed that the DI assessment of
the blood cells could be made by means of our high speed
video camera, with minimal dragging of the cells.
Figure 5 shows the DIs of the blood cells (RBCs and
PBMCs) flowing along the axial position of a hyperbolic
channel with a sudden expansion, as well as the average or
pseudo shear rate, γ ¼ UDh, at each hyperbolic region, where U
is the mean velocity of the blood cells obtained at each region
andDh is the hydraulic diameter of eachmicrochannel section.
Overall, the DI of both cells has a maximum value at the
region right before the exit of the contraction, where the aver-
age shear rate is also the highest (1761.6 s−1). In fact, the
maximum average shear rate obtained at the narrowest region
is in good agreement with the shear rate values encountered in
arterioles (~1600 s−1), which have dimensions similar to the
hyperbolic contractions used in this work (~ 20 μm)
(Papaioannou and Stefanadis 2005). After the narrowest sec-
tion, cells tend to recover to its initial shape that corresponds to
a minimal value of the DI, where cells are no longer exposed
to extensional flow and the average shear rate reduces to ex-
tremely low value (60.7 s−1), similarly to the values encoun-
tered at large veins. Moreover, the shear stress encountered in
the arterioles (shear rate ~1600 s−1) is around 55 dyn/cm2 and
this value decreases to 5 dyn/cm2 at large veins, where the
shear rate is~100 s−1 (Papaioannou and Stefanadis 2005).
Therefore, our results show that both shear and extensional
flows generated by the hyperbolic channels promote cell re-
sponse to shear stress in a similar way that happens in in vivo
environments.
Figure 5 also shows the difference between the DI obtained
by the RBCs and PBMCs when exposed to the same strong
extensional flow and shear stress conditions. It should be not-
ed that the hyperbolic contraction geometry to measure the
cells deformability with a Hencky strain of~3 was chosen
mainly due to the strong extensional flow generated in the
middle of the microchannel, which is dominant over the shear
flow. To better understand the influence of the extensional
flow and shear stress on the deformability of both RBCs and
PBMCs, average DI values at the two key regions of the
microchannel (narrow and recuperation section) were selected
and defined as section 1 and 2 (Fig. 6).
The first DI measurement was made in the hyperbolic con-
striction section (section 1) that promotes the elongation of the
cells caused by the strong extensional and shear flow (Lee et al.
2009; Yaginuma et al. 2013). The second DI assessment was
measured in the recovery section caused by the sudden expan-
sion (section 2), where the recovery to the normal size and shape
of the blood cells can be seen. These two DIs assessment pro-
vided a better understanding of the deformation phenomenon by
showing the different behaviour that blood cells have when sub-
jected to the same strong extensional flow and high shear rate
(section 1) and then the recovery of their initial shape, which
Table 1 Separation results of the PBMCs in continuous flow rate at
100 μL/min using a simple cross-flow filtration microdevice
Microdevice section PBMCs±SD (104 cells/mL) PBMCs (%)
Outlet 1 19±4.8 22
Outlet 2,3 46±7.9 52
Outlet 4 22±6.0 26
Results are presented asMean±Standard Deviation (104 cells/mL) and in
percentage (%) (n=6)
PBMC Peripheral blood mononuclear cells
Fig. 4 Blood cells flowing
through cross-flow filtration
barrier to the direction of the
outlets and hyperbolic chamber
for their further DI assessment
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corresponds to a minimal value of the DI, where cells are no
longer exposed to these deformable hemodynamic conditions
(section 2). The results show that PBMCs, when submitted to
a strong extensional flow and high flow rate, can reach a maxi-
mumDI of 0.10, followed by a small decrease of the DI to about
0.06, in the recovery section (n=76). It is worth mentioning that
similar results were obtained by Gossett et al. (2012), regarding
the deformation of untreated PBMCs subjected to a stretching
extensional flow in a microfluidic deformability cytometer. By
calculating the DI in the same way that Gossett et al. (2012)
(length of the longer axis divided by the perpendicular of the
shorter axis), our results shown a mean deformation of PBMCs
about 1.21±0.13 (n=76), which is in good agreement with the
data obtained by Gossett et al. (2012) where the mean deforma-
tion of these blood cells were calculated to be 1.18 (n=377).
These results reveal that PBMCs under the applied in vitro con-
ditions tend to behave as a non-deformed cell, indicating the
importance of the pro-inflammatory mediators (cytokines,
chemokines or bacterial peptides) have into the deformation of
these cells, as observed in in vivo (Liu and Wang 2004) for the
active WBCs deformation. Additionally, the results show the
importance of the leukocyte-endothelial cell interaction, which
is intimately linked to the cytoskeleton structures of the WBCs
(namely the microvilli projections of them) and the nucleus con-
tent (e.g., cytoplasm viscosity). In fact, the cytoskeleton structure
and internal composition of the WBCs are the main reasons for
the rolling and arrest (firm adhesion) phenomena that allows
their capture from the blood flow by the endothelial cells and
further migration of these blood cells to search for bacteria or
fungi through the body (Khismatullin 2009). These phenomena
(specially the rolling) were also observed in this study along the
whole microfluidic device (either in the cross-flow pillars, as
shown in Fig. 3 and supplementary video 1, and in the hyper-
bolic channels), which we believe is the main reason for the
difference of blood cells contents (WBCs and RBCs) that we
have observed in the four outlets, as well as for the lower
deformability observed in the hyperbolic channel, when com-
pared with the RBCs DIs. Moreover, Fig. 6 shows that the
RBCs, when submitted to the same strong extensional flow
and high shear rate, tend to elongate (especially when they travel
along the centreline of the hyperbolic section), reaching a max-
imum DI of 0.44±0.04, which corresponds fourfold higher than
the deformability reached by PBMCs.Also, it can be observed in
this figure that this high RBC deformability is followed by a
dramatic decrease of their DI to 0.24±0.05. This latter result
corroborate with the ones obtained by Lee et al. (2009) and
Yaginuma et al. (2013), where they found that RBCs change
Fig. 5 Deformation index of blood cell (RBCs and PBMCs) flowing
along the axial position of the hyperbolic channel followed by a sudden
expansion (red and black dots), as well as the average shear rate at each
hyperbolic region (dotted line). Error bars shows a 95 % of confidence
interval (n=168 blood cells)
Fig. 6 Averaged deformation index obtained from PBMCs and RBCs
flowing within the hyperbolic and recuperation section of the
microchannel device. Error bars shows a 95 % of confidence interval
(n=168)
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from a nearly circular to an elliptical shape and become
increasingly elongated as they flow through a hyperbolic
contraction. Hence, the results obtained by this study indicate
that RBCs under in vitro and passive hemodynamic conditions,
presents higher deformability behaviour when compared to the
PBMCs deformability results. Since the WBCs are naturally
known as deformable cells in their biological environment, this
paradoxical in vitro results corroborated the fact that Gossett
et al. (2012) pointed to the relevance of pro-inflammatory medi-
ators in the activation of the deformation behaviour of these
blood cells, as well as for the importance to study themechanical
properties of each type of WBCs when subjected to passive
deformability. Additionally, these in vitro hemodynamic behav-
iours encountered among different blood cells may have the
potential to become a new μTAS able to use these findings to
improve the separation of different blood cells from the whole
blood based on their natural and passive hydrodynamic behav-
iour, and therefore, eventually, allowing the development of a
simple and disposable clinical microfluidic system.
4 Conclusions
In this work we have successfully designed, fabricated and
tested a novel microfluidic device able to perform continuous-
ly and simultaneously both separation of a certain amount of
blood cells from an initial blood sample, as well as to assess
the deformability of them, by using respectively, cross-flow
microfilters and hyperbolic microchannels. The cross-flow fil-
tration strategy has shown the ability to separate from the
initial in vitro blood sample, approximately 25 % of PBMCs
and to collect directly to the two outlets located downstream of
this barrier. This separation efficiency was proven to be the
most adequate way to assess blood cells deformability by
using our high-speed video microscopy system. The major
advantage of this separation technique was the ability to in-
vestigate, for the first time, the effect of extensional-
dominated flows on the deformability of both PBMCs and
RBCs under the same in vitro conditions using hyperbolic
chambers. The DI results have shown that PBMCs have a
non-deformable behaviour when subjected to passive hemo-
dynamic conditions even with a strong extensional flows,
which is in good agreement with the recently published study
performed by Gossett et al. (2012). In contrast, RBCs have
shown to have a much higher deformable behaviour when
subjected to the same in vitro conditions (fourfold higher than
the deformability reached by PBMCs). Although there are
many advantages with the proposed microfluidic device, in-
cluding its low cost, ease of fabrication and cell separation
simplicity, its biggest challenges are its ability to perform
whole blood cells separation without any problems of clog-
ging or jamming and the need to use a high-speed video mi-
croscopy system to measure the cells deformability. Further
improvements in the proposed microfluidic design and the
integration of optical components within the device are ex-
pected to lead to the creation of a novel μTAS for routine cell
screening in clinical and research applications.
Acknowledgments The authors acknowledge the financial support
provided by PTDC/SAU-ENB/116929/2010 and EXPL/EMS-SIS/
2215/2013 from FCT (Fundação para a Ciência e a Tecnologia), COM-
PETE, QREN and European Union (FEDER). R. O. Rodrigues, D. Pinho
and V. Faustino acknowledge respectively, the PhD scholarships
SFRH/BD/97658/2013, SFRH/BD/89077/2012 and SFRH/BD/99696/
2014 granted by FCT. The authors would also like to thank Dr. Ângela
Fernandes for providing the blood samples and Dr. Ricardo Calhelha for
supplying the tissue culture medium used in this work.
References
G.C. Agbangla, É. Climent, P. Bacchin, Sep. Purif. Technol. 101, 42–48
(2012)
E.L. Bradley, L. Bernard, P. Thomas, J. Brian, J. Micromech. Microeng.
22, 025009 (2012)
X. Chen, D. Cui, C. Liu, H. Li, J. Chen, Anal. Chim. Acta 584, 237–243
(2007)
X. Chen, D.F. Cui, C.C. Liu, H. Li, Sens. Actuators B Chem. 130, 216–
221 (2008)
R. Covar, M. Gleason, B. Macomber, L. Stewart, P. Szefler, K.
Engelhardt, J. Murphy, A. Liu, S. Wood, S. DeMichele, E.W.
Gelfand, S.J. Szefler, Clin. Exp. Allergy 40, 1163–1174 (2010)
V. Faustino, D. Pinho, T. Yaginuma, R. Calhelha, I.F.R. Ferreira, R. Lima,
BioChip J. 8, 42–47 (2014)
A.E. Frampton, C.E. Fletcher, T.M. Gall, L. Castellano, C.L. Bevan, J.
Stebbing, J. Krell, Expert. Rev. Mol. Diagn. 13, 425–430 (2013)
J. Fu, B.E. Sha, L.L. Thomas, J. Acquir. Immune Defic. Syndr. 56, 16–25
(2011)
K. Georgieva, D.J. Dijkstra, H. Fricke, N. Willenbacher, J. Colloid
Interface Sci. 352, 265–277 (2010)
D.R. Gossett, W.M. Weaver, A.J. Mach, S.C. Hur, H.T. Tse, W. Lee, H.
Amini, D. Di Carlo, Anal. Bioanal. Chem. 397, 3249–3267 (2010)
D.R. Gossett, H.T.K. Tse, S.A. Lee, Y. Ying, A.G. Lindgren, O.O. Yang,
J. Rao, A.T. Clark, D. Di Carlo, Proc. Natl. Acad. Sci. U. S. A. 109,
7630–7635 (2012)
H.W. Hou, A.A. Bhagat, A.G. Chong, P. Mao, K.S. Tan, J. Han, C.T.
Lim, Lab Chip 10, 2605–2613 (2010)
H.M. Ji, V. Samper, Y. Chen, C.K. Heng, T.M. Lim, L. Yobas, Biomed.
Microdevices 10, 251–257 (2008)
Z. Jinlong, G. Qiuquan, L. Mei, Y. Jun, J. Micromech. Microeng. 18,
125025 (2008)
D.B. Khismatullin, in Leukocyte rolling and adhesion: Current topics in
membranes, ed. by K. Ley, vol. 64 (Academic, New York, 2009),
pp. 47–111
M. Kim, S. Mo Jung, K.H. Lee, Y. Jun Kang, S. Yang, Artif. Organs 34,
996–1002 (2010)
V. Leble, R. Lima, R. Dias, C. Fernandes, T. Ishikawa, Y. Imai, T.
Yamaguchi, Biomicrofluidics 5, 044120-044120-044115 (2011)
S. Lee, Y. Yim, K. Ahn, S. Lee, Biomed. Microdevices 11, 1021–1027
(2009)
R. Lima, S. Wada, S. Tanaka, M. Takeda, T. Ishikawa, K. Tsubota, Y.
Imai, T. Yamaguchi, Biomed. Microdevices 10, 153–167 (2008)
X.H. Liu, X. Wang, J. Biomech. 37, 1079–1085 (2004)
W. Luttmann, K. Bratke, M. Kupper, D. Myrtek, Immunology, vol. 1
(Elsevier, Philadelphia, 2006)
E.Maes, B. Landuyt, I. Mertens, L. Schoofs, PLoS One 8, e61933 (2013)
108 Page 8 of 9 Biomed Microdevices (2015) 17: 108
E. Meijering, I. Smal, G. Danuser, IEEE Signal Process. Mag. 23, 46–53
(2006)
S. Metz, C. Trautmann, A. Bertsch, R. Ph, J. Micromech. Microeng. 14,
324 (2004)
S.K. Murthy, P. Sethu, G. Vunjak-Novakovic, M. Toner, M. Radisic,
Biomed. Microdevices 8, 231–237 (2006)
E. Ortega, R. Gilabert, I. Nuñez, M. Cofán, A. Sala-Vila, E. de Groot, E.
Ros, Atherosclerosis 221, 275–281 (2012)
T.G. Papaioannou, C. Stefanadis, Hellenic J. Cardiol. 46, 9–15 (2005)
D. Pinho, T. Yaginuma, R. Lima, BioChip J. 7, 367–374 (2013)
A. Sabo, V. Jakovljevic, M. Stanulovic, L. Lepsanovic, D. Pejin, Int. J.
Clin. Pharmacol. Ther. Toxicol. 31, 1–5 (1993)
S.S. Shevkoplyas, T. Yoshida, L.L. Munn, M.W. Bitensky, Anal. Chem.
77, 933–937 (2005)
Sigma-Aldrich, Histopaque-1077: product information. St. Louis, MO,
USA, (2011)
R. Suwanarusk, B.M. Cooke, A.M. Dondorp, K. Silamut, J.
Sattabongkot, N.J. White, R. Udomsangpetch, J. Infect. Dis. 189,
190–194 (2004)
K. Tae Goo, Y. Yong-Jin, J. Hongmiao, L. Pei Yi, C. Yu, J. Micromech.
Microeng. 24, 087001 (2014)
M. Tanino, R. Matoba, S. Nakamura, H. Kameda, K. Amano, T.
Okayama, H. Nagasawa, K. Suzuki, K. Matsubara, T. Takeuchi,
Biochem. Biophys. Res. Commun. 387, 261–265 (2009)
V. VanDelinder, A. Groisman, Anal. Chem. 78, 3765–3771 (2006)
V. VanDelinder, A. Groisman, Anal. Chem. 79, 2023–2030 (2007)
T. Yaginuma, M.S.N. Oliveira, R. Lima, T. Ishikawa, T. Yamaguchi,
Biomicrofluidics 7, 054110 (2013)
X. Yang, J.M. Yang, Y.-C. Tai, C.-M. Ho, Sensors Actuators A Phys. 73,
184–191 (1999)
Y.T. Yaylali, I. Susam, E. Demir, M. Bor-Kucukatay, B. Uludag, E. Kilic-
Toprak, G. Erken, D. Dursunoglu, J. Coron. Artery Dis. 24, 11–15
(2013)
Biomed Microdevices (2015) 17: 108 Page 9 of 9 108
